Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.693 USD | +0.87% | +18.28% | -68.36% |
03/06 | Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies | CI |
15/05 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.36% | 63.41L | |
+10.16% | 19TCr | |
+26.21% | 15TCr | |
+32.78% | 11TCr | |
+1.98% | 6.5TCr | |
+14.48% | 5.28TCr | |
+2.92% | 4.94TCr | |
-6.60% | 3.81TCr | |
-1.07% | 3.51TCr | |
+23.08% | 3.12TCr |
- Stock Market
- Equities
- AEMD Stock
- News Aethlon Medical, Inc.
- Aethlon Medical Pares Fiscal Q3 Loss per Share as Revenue Plunges